Výsledky vyhledávání - "Kirsten Myhr"

Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study

Autor: Unni Gopinathan, Kirsten Myhr, Fatima Tauqeer

Publikováno v: Health Policy and Planning

Complying with good manufacturing practices (GMP) and ensuring a quality system is integral to production and supply of quality medicines and achieving universal health coverage. This study focus on the local production of medicines in Pakistan, a lo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c19a305f8c2bacf8c661c437bf28d6e
http://europepmc.org/articles/PMC6736431

Zobrazit plný text záznamu

Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system

Autor: Vigdis Solhaug, Kirsten Myhr, Per Wiik Johansen, Odd Brørs, Sigrid Narum, Marianne K. Kringen

Publikováno v: British Journal of Clinical Pharmacology. 71:254-262

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Bleeding is the main adverse drug reaction of warfarin use. • Several medicines, herbal products and dietary supplements may interact with warfarin. • A high percentage of patients on warfarin receive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4536e0dc848550436c09b0baf963a65a
https://doi.org/10.1111/j.1365-2125.2010.03827.x

Zobrazit plný text záznamu

Venlafaxine and asthma

Autor: Odd Brørs, Kirsten Myhr, Tone Skaali, Øyvind Melien

Publikováno v: Nordic Journal of Psychiatry. 59:538-540

A 54-year-old man of Asian origin with major depression developed an asthma-like reaction during venlafaxine treatment. Two weeks after therapy was initiated, he experienced gradually worsening dry cough at night and periodically dyspnea during the d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7fad9ddd9e8a15049bf147321244a7
https://doi.org/10.1080/08039480500363595

Zobrazit plný text záznamu

Plný text ve formátu HTML

Impact of improved treatment of sexually transmitted disease on HIV infection

Publikováno v: The Lancet. 346:1157-1160

Grosskurth and colleagues report the outcomes of a randomized controlled trial to evaluate the impact of improved treatment of sexually transmitted diseases (STD) on HIV infection. The authors congratulate the research team on the high quality of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f5207853bf097787f9ae61ca91e13dfe
https://doi.org/10.1016/s0140-6736(95)91830-2

Zobrazit plný text záznamu

Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system

Autor: Marianne K. Kringen, Sigrid Narum, Vigdis Solhaug, Kirsten Myhr, Odd Brørs

Publikováno v: European journal of clinical pharmacology. 69(7)

The aim of the study was to analyse non-warfarin-associated bleeding adverse drug events reported to the Norwegian spontaneous reporting system, with characterisation of the bleeding locations, outcome and drug interactions. In addition, concordance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0f01b34c188f8f20be2aa953dba71c5
https://pubmed.ncbi.nlm.nih.gov/23423243

Zobrazit plný text záznamu

BigPharma and unethical marketing of medicinal products

Autor: Kirsten Myhr

Publikováno v: Southern Med Review

In today's environment, the main focus of the critical mass towards the multinational companies is on access to new patented and more expensive products. Many of them essential medicines, but many more non-essential 'me-too' medicines developed to ge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdde69604696b9986ed7dbba26b7a19f
https://pubmed.ncbi.nlm.nih.gov/23093891

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání